Position in TNYA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$255,968
+$40,996 QoQ
Shares Held
346,371
+11.5% QoQ
Ownership
0.154%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 101 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TNYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,537,836 across 424 Biotechnology names. TNYA ranks #307 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in TNYA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $255,968 | 346,371 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $214,972 | 310,654 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $172,004 | 241,580 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $387,972 | 239,489 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $79,090 | 129,445 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $253,672 | 445,040 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $675,643 | 472,479 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $858,554 | 444,847 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,221,412 | 394,004 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,079,766 | 397,661 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,262,569 | 389,682 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,094,544 | 429,233 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,451,358 | 417,608 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $991,639 | 347,944 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $448,454 | 223,112 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $669,374 | 230,819 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,250,506 | 222,115 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,726,587 | 231,459 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,650,593 | 139,873 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $2,545,937 | 123,290 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||